Vilex completed the acquisition of DT MedTech, manufacturer of the Hintermann Series System™ Total Ankle Replacement. DT MedTech will become a wholly owned subsidiary of Vilex and will continue to market its products outside the U.S. through its existing distribution network. The Hintermann devices will be supported in the U.S. through the sales organization of Tennessee-based Vilex.
With the transaction, Vilex gains the Hintermann H3® 3-piece, mobile-bearing total ankle and the Hintermann Series H2® 2-piece, semi-constrained total ankle. H2 is FDA 510(k) cleared, and the H3 is FDA approved. Both are sold globally in over 30 countries. No other company in the world offers both a mobile bearing and a semi-constrained TAR system that uses a single surgical approach and a single instrument set.
The total ankle systems complement Vilex’s trauma devices for the extremities, such as cannulated screws, staples, plates, an external fixator system, etc.
Dustin Leavitt, Chief Executive Officer of Vilex, said, “The merging of our widely recognized Vilex product line in the U.S. with the globally-renowned, clinically-proven, Hintermann Series product portfolio positions Vilex as a global leader in providing lower extremity surgical solutions. The combined commercial channel now includes more than 50 distributors in the U.S. and over 25 distribution partners outside the U.S., comprising over 300 field representatives, and many long-standing institutional customers.”
Vilex completed the acquisition of DT MedTech, manufacturer of the Hintermann Series System™ Total Ankle Replacement. DT MedTech will become a wholly owned subsidiary of Vilex and will continue to market its products outside the U.S. through its existing distribution network. The Hintermann devices will be supported in the U.S. through the...
Vilex completed the acquisition of DT MedTech, manufacturer of the Hintermann Series System™ Total Ankle Replacement. DT MedTech will become a wholly owned subsidiary of Vilex and will continue to market its products outside the U.S. through its existing distribution network. The Hintermann devices will be supported in the U.S. through the sales organization of Tennessee-based Vilex.
With the transaction, Vilex gains the Hintermann H3® 3-piece, mobile-bearing total ankle and the Hintermann Series H2® 2-piece, semi-constrained total ankle. H2 is FDA 510(k) cleared, and the H3 is FDA approved. Both are sold globally in over 30 countries. No other company in the world offers both a mobile bearing and a semi-constrained TAR system that uses a single surgical approach and a single instrument set.
The total ankle systems complement Vilex’s trauma devices for the extremities, such as cannulated screws, staples, plates, an external fixator system, etc.
Dustin Leavitt, Chief Executive Officer of Vilex, said, “The merging of our widely recognized Vilex product line in the U.S. with the globally-renowned, clinically-proven, Hintermann Series product portfolio positions Vilex as a global leader in providing lower extremity surgical solutions. The combined commercial channel now includes more than 50 distributors in the U.S. and over 25 distribution partners outside the U.S., comprising over 300 field representatives, and many long-standing institutional customers.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
